An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes

被引:49
作者
Farmer, Andrew [1 ]
Hardeman, Wendy [2 ]
Hughes, Dyfrig [3 ]
Prevost, A. Toby [4 ]
Kim, Youngsuk [2 ]
Craven, Anthea [1 ]
Oke, Jason [1 ]
Boase, Sue [2 ]
Selwood, Mary [1 ]
Kellar, Ian [2 ]
Graffy, Jonathan [2 ]
Griffin, Simon [5 ]
Sutton, Stephen [2 ]
Kinmonth, Ann-Louise [2 ]
机构
[1] Univ Oxford, Dept Primary Hlth Care Sci, Oxford, England
[2] Univ Cambridge, Gen Practice & Primary Care Res Unit, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England
[3] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales
[4] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England
[5] MRC, Clin Epidemiol Unit, Cambridge, England
基金
英国医学研究理事会;
关键词
Adherence; Brief intervention; Diabetes; METFORMIN; BELIEFS; DISEASE; PEOPLE; SCALES; DRUGS;
D O I
10.1186/1471-2296-13-30
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Failure to take medication reduces the effectiveness of treatment leading to increased morbidity and mortality. We evaluated the efficacy of a consultation-based intervention to support objectively-assessed adherence to oral glucose lowering medication (OGLM) compared to usual care among people with type 2 diabetes. Methods: This was a parallel group randomised trial in adult patients with type 2 diabetes and HbA(1c)>= 7.5% (58 mmol/mol), prescribed at least one OGLM. Participants were allocated to a clinic nurse delivered, innovative consultation-based intervention to strengthen patient motivation to take OGLM regularly and support medicine taking through action-plans, or to usual care. The primary outcome was the percentage of days on which the prescribed dose of medication was taken, measured objectively over 12 weeks with an electronic medication-monitoring device (TrackCap, Aardex, Switzerland). The primary analysis was intention-to-treat. Results: 211 patients were randomised between July 1, 2006 and November 30, 2008 in 13 British general practices (primary care clinics). Primary outcome data were available for 194 participants (91.9%). Mean (sd) percentage of adherent days was 77.4% (26.3) in the intervention group and 69.0% (30.8) in standard care (mean difference between groups 8.4%, 95% confidence interval 0.2% to 16.7%, p = 0.044). There was no significant adverse impact on functional status or treatment satisfaction. Conclusions: This well-specified, theory based intervention delivered in a single session of 30 min in primary care increased objectively measured medication adherence, with no adverse effect on treatment satisfaction. These findings justify a definitive trial of this approach to improving medication adherence over a longer period of time, with clinical and cost-effectiveness outcomes to inform clinical practice.
引用
收藏
页数:9
相关论文
共 29 条
[1]   THE THEORY OF PLANNED BEHAVIOR [J].
AJZEN, I .
ORGANIZATIONAL BEHAVIOR AND HUMAN DECISION PROCESSES, 1991, 50 (02) :179-211
[2]   DISCONTINUATION OF ANTIHYPERLIPIDEMIC DRUGS - DO RATES REPORTED IN CLINICAL-TRIALS REFLECT RATES IN PRIMARY-CARE SETTINGS [J].
ANDRADE, SE ;
WALKER, AM ;
GOTTLIEB, LK ;
HOLLENBERG, NK ;
TESTA, MA ;
SAPERIA, GM ;
PLATT, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) :1125-1131
[3]  
[Anonymous], 2013, Adherence to Long-Term Therapies: Evidence for Action, DOI [10.4028/www.scientific.net/AMM.321-324.1779, DOI 10.4028/WWW.SCIENTIFIC.NET/AMM.321-324.1779]
[4]   Should we consider non-compliance a medical error? [J].
Barber, N .
QUALITY & SAFETY IN HEALTH CARE, 2002, 11 (01) :81-84
[5]   Patients' decisions about whether or not to take antihypertensive drugs: qualitative study [J].
Benson, J ;
Britten, N .
BRITISH MEDICAL JOURNAL, 2002, 325 (7369) :873-876A
[6]   Secondary prevention of coronary heart disease: Patient beliefs and health-related behaviour [J].
Byrne, M ;
Walsh, J ;
Murphy, AW .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2005, 58 (05) :403-415
[7]   A systematic review of adherence with medications for diabetes [J].
Cramer, JA .
DIABETES CARE, 2004, 27 (05) :1218-1224
[8]   Patient adherence and medical treatment outcomes - A meta-analysis [J].
DiMatteo, MR ;
Giordani, PJ ;
Lepper, HS ;
Croghan, TW .
MEDICAL CARE, 2002, 40 (09) :794-811
[9]   Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes [J].
Farmer, A ;
Kinmonth, AL ;
Sutton, S .
DIABETIC MEDICINE, 2006, 23 (03) :265-270
[10]   Protocol for SAMS (Support and Advice for Medication Study): A randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication [J].
Farmer, Andrew J. ;
Prevost, A. Toby ;
Hardeman, Wendy ;
Craven, Anthea ;
Sutton, Stephen ;
Griffin, Simon J. ;
Kinmonth, Ann-Louise .
BMC FAMILY PRACTICE, 2008, 9 (1)